Related references
Note: Only part of the references are listed.Zonisamide Versus Topiramate in Migraine Prophylaxis: A Double-Blind Randomized Clinical Trial
Seyed Ehsan Mohammadianinejad et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Immuno- and antiinflammatory therapies in epileptic disorders
Cigdem Ozkara et al.
EPILEPSIA (2011)
Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
Takahisa Hanada et al.
EPILEPSIA (2011)
Antiepileptic drug discovery: Does mechanism of action matter?
Dieter Schmidt
EPILEPSY & BEHAVIOR (2011)
Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: A pharmacodynamic interaction?
Jan Novy et al.
EPILEPSY & BEHAVIOR (2011)
Antiepileptic drug therapy: Does mechanism of action matter?
Martin J. Brodie et al.
EPILEPSY & BEHAVIOR (2011)
The pharmacological treatment of epilepsy in adults
Emilio Perucca et al.
LANCET NEUROLOGY (2011)
Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma
M. de Groot et al.
NEUROLOGY (2011)
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
J. A. French et al.
NEUROLOGY (2011)
Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors
Nasir S. Mirza et al.
PHARMACOGENETICS AND GENOMICS (2011)
Management of Seizures in Lennox-Gastaut Syndrome
Patricia K. Crumrine
PEDIATRIC DRUGS (2011)
A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs
John-Kenneth Sake et al.
CNS DRUGS (2010)
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis
Stefan Beyenburg et al.
EPILEPSIA (2010)
A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures
Michel Baulac et al.
EPILEPSY RESEARCH (2010)
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
Meir Bialer et al.
EPILEPSY RESEARCH (2010)
Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder
Frederik Rode et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
RECENT ADVANCES IN ADJUNCTIVE THERAPY FOR EPILEPSY: FOCUS ON SODIUM CHANNEL BLOCKERS AS THIRD-GENERATION ANTIEPILEPTIC DRUGS
D. Vohora et al.
DRUGS OF TODAY (2010)
Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial
Martin J. Brodie et al.
EPILEPSIA (2009)
Adverse effects of antiepileptic drugs
Rafael Toledano et al.
SEMINARS IN NEUROLOGY (2008)
The Investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels
Adam C. Errington et al.
MOLECULAR PHARMACOLOGY (2008)
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
Elinor Ben-Menachem
EPILEPSIA (2007)
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Emilio Perucca et al.
LANCET NEUROLOGY (2007)
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
Frank H. Yu et al.
NATURE NEUROSCIENCE (2006)
ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2006)
The neurobiology of antiepileptic drugs
MA Rogawski et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet
EH Kossoff et al.
EPILEPSIA (2002)
Selection of antiepileptic drug polytherapy based on mechanisms of action: The evidence reviewed
CLP Deckers et al.
EPILEPSIA (2000)
Share Paper
